In this brief interview courtesy of MediconValley TV, Glen Giovannetti, global biotechnology leader at Ernst & Young, discusses the biotechnology industry and the current economic crisis. Although the short term prognosis may be challenging, Giovanetti …

Venture capitalists invested $4.8 billion in 637 deals in the third quarter of 2009, according to the MoneyTree™ Report from PricewaterhouseCoopers LLP (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters.

In Business Facilities Magazine’s recently released 2009 Biotechnology Strength Report, Ohio is once again ranked fourth among all states.

Via The N.Y. Times:
“With health care reform and economic recovery sucking up so much of what little oxygen circulates in Washington, you’ll have to forgive The Agenda for only now turning to the Small Business …